HAVCR2 and neoplasm: Studies have shown that TIM-3, through binding to its ligand phosphatidylserine (PtdSer), induces inhibition of downstream signaling pathways such as PI3K/mTOR, which in turn leads to dysregulation of NK cells and tumor evasion of the immune (6).